Matthew Hamilton Rosenberg’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $176K | Buy |
3,799
+2,153
| +131% | +$99.7K | 0.04% | 225 |
|
|
2025
Q1 | $100K | Sell |
1,646
-59
| -3% | -$3.6K | 0.03% | 315 |
|
|
2024
Q4 | $96.4K | Buy |
1,705
+694
| +69% | +$39.3K | 0.03% | 320 |
|
|
2024
Q3 | $52.3K | Hold |
1,011
| – | – | 0.01% | 419 |
|
|
2024
Q2 | $41.8K | Sell |
1,011
-1,646
| -62% | -$68K | 0.01% | 447 |
|
|
2024
Q1 | $141K | Buy |
2,657
+373
| +16% | +$19.8K | 0.04% | 249 |
|
|
2023
Q4 | $117K | Sell |
2,284
-282
| -11% | -$14.5K | 0.04% | 274 |
|
|
2023
Q3 | $149K | Sell |
2,566
-423
| -14% | -$24.6K | 0.05% | 220 |
|
|
2023
Q2 | $191K | Buy |
2,989
+99
| +3% | +$6.33K | 0.06% | 179 |
|
|
2023
Q1 | $200K | Sell |
2,890
-133
| -4% | -$9.22K | 0.06% | 185 |
|
|
2022
Q4 | $218K | Buy |
3,023
+205
| +7% | +$14.8K | 0.07% | 165 |
|
|
2022
Q3 | $200K | Buy |
2,818
+45
| +2% | +$3.19K | 0.08% | 159 |
|
|
2022
Q2 | $213K | Buy |
2,773
+226
| +9% | +$17.4K | 0.08% | 158 |
|
|
2022
Q1 | $186K | Hold |
2,547
| – | – | 0.07% | 197 |
|
|
2021
Q4 | $159K | Sell |
2,547
-565
| -18% | -$35.3K | 0.06% | 226 |
|
|
2021
Q3 | $184K | Buy |
3,112
+543
| +21% | +$32.1K | 0.07% | 176 |
|
|
2021
Q2 | $172K | Buy |
2,569
+272
| +12% | +$18.2K | 0.09% | 160 |
|
|
2021
Q1 | $145K | Buy |
2,297
+357
| +18% | +$22.5K | 0.08% | 179 |
|
|
2020
Q4 | $114K | Buy |
1,940
+153
| +9% | +$8.99K | 0.07% | 212 |
|
|
2020
Q3 | $108K | Sell |
1,787
-60
| -3% | -$3.63K | 0.08% | 188 |
|
|
2020
Q2 | $109K | Buy |
1,847
+2
| +0.1% | +$118 | 0.09% | 170 |
|
|
2020
Q1 | $103K | Buy |
+1,845
| New | +$103K | 0.1% | 114 |
|